← Evidence map

ArticleESMO gastrointestinal oncology2025

Early-onset enriches the identification of actionable alterations in patients with

E Scarlato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41646273